PH12022553441A1 - Compositions and methods for treating obsessive-compulsive disorder - Google Patents

Compositions and methods for treating obsessive-compulsive disorder

Info

Publication number
PH12022553441A1
PH12022553441A1 PH1/2022/553441A PH12022553441A PH12022553441A1 PH 12022553441 A1 PH12022553441 A1 PH 12022553441A1 PH 12022553441 A PH12022553441 A PH 12022553441A PH 12022553441 A1 PH12022553441 A1 PH 12022553441A1
Authority
PH
Philippines
Prior art keywords
compulsive disorder
compositions
methods
treating obsessive
obsessive
Prior art date
Application number
PH1/2022/553441A
Other languages
English (en)
Inventor
Loren Aguiar
Robert Berman
Vladimir Coric
Original Assignee
Biohaven Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohaven Therapeutics Ltd filed Critical Biohaven Therapeutics Ltd
Publication of PH12022553441A1 publication Critical patent/PH12022553441A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH1/2022/553441A 2020-06-24 2021-06-24 Compositions and methods for treating obsessive-compulsive disorder PH12022553441A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063043681P 2020-06-24 2020-06-24
PCT/US2021/038789 WO2021262914A1 (en) 2020-06-24 2021-06-24 Compositions and methods for treating obsessive-compulsive disorder

Publications (1)

Publication Number Publication Date
PH12022553441A1 true PH12022553441A1 (en) 2024-03-04

Family

ID=79281806

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2022/553441A PH12022553441A1 (en) 2020-06-24 2021-06-24 Compositions and methods for treating obsessive-compulsive disorder

Country Status (12)

Country Link
US (1) US20230181541A1 (cg-RX-API-DMAC7.html)
EP (1) EP4171554A4 (cg-RX-API-DMAC7.html)
JP (1) JP7805969B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230027189A (cg-RX-API-DMAC7.html)
CN (1) CN115968312A (cg-RX-API-DMAC7.html)
AU (1) AU2021297249A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022025901A2 (cg-RX-API-DMAC7.html)
CA (1) CA3187323A1 (cg-RX-API-DMAC7.html)
IL (1) IL299301A (cg-RX-API-DMAC7.html)
MX (1) MX2022016174A (cg-RX-API-DMAC7.html)
PH (1) PH12022553441A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021262914A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP2400349A1 (hu) * 2024-07-05 2026-01-28 Egis Gyógyszergyár Zrt. Troriluzole-hidroklorid-sók

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2819303T3 (es) 2005-04-05 2021-04-15 Univ Yale Agentes moduladores del glutamato en el tratamiento de trastornos mentales
DK3265448T3 (da) 2015-03-03 2022-03-28 Biohaven Therapeutics Ltd Riluzol-prodrugs og anvendelse deraf
DK3297619T3 (da) 2015-05-22 2022-08-15 Vistagen Therapeutics Inc Terapeutiske anvendelser af L-4-chlorkynurenin
US10751345B2 (en) 2018-02-21 2020-08-25 AI Therapeutics, Inc. Combination therapy with apilimod and glutamatergic agents
CN112203692A (zh) 2018-05-27 2021-01-08 拜尔哈文制药股份有限公司 利鲁唑口腔崩解片用于治疗疾病的用途
JP2021530543A (ja) 2018-07-22 2021-11-11 バイオヘイブン・セラピューティクス・リミテッドBiohaven Therapeutics Ltd. アルツハイマー病を処置するためのリルゾールプロドラッグの使用
CN112584831A (zh) 2018-08-16 2021-03-30 拜奥海芬治疗学有限公司 利鲁唑口腔崩解片用于治疗疾病的用途

Also Published As

Publication number Publication date
CN115968312A (zh) 2023-04-14
KR20230027189A (ko) 2023-02-27
EP4171554A1 (en) 2023-05-03
JP2023531919A (ja) 2023-07-26
JP7805969B2 (ja) 2026-01-26
AU2021297249A1 (en) 2023-02-23
CA3187323A1 (en) 2021-12-30
MX2022016174A (es) 2023-01-24
BR112022025901A2 (pt) 2023-01-10
IL299301A (en) 2023-02-01
WO2021262914A1 (en) 2021-12-30
US20230181541A1 (en) 2023-06-15
EP4171554A4 (en) 2024-07-31

Similar Documents

Publication Publication Date Title
ZA202109010B (en) Compounds and methods for the treatment of covid-19
MX2011007854A (es) Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
NZ630367A (en) Methods of treatment of pediatric solid tumor
MX2024014121A (es) Metodos y composiciones para el tratamiento del exceso de glucocorticoides
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
WO2022010813A3 (en) Enhancing immune responses through targeted antigen expression
MX2023003723A (es) Anticuerpos anti-il-36r para el tratamiento de dolor inflamatorio cronico.
MX2020007817A (es) Prevención y tratamiento del trastorno del sueño.
MX2022016174A (es) Composiciones y metodos para tratar un trastorno obsesivo-compulsivo.
MX2020007222A (es) Metodos para el tratamiento de afecciones inflamatorias de la piel.
MX2023001233A (es) Metodos de tratamiento del cancer positivo para her2 con tucatinib en combinacion con trastuzumab, un taxano y un antagonista del vegfr-2.
MY200247A (en) Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitors
PH12021553055A1 (en) Methods and compositions for improving outcomes of cancer patients
MX2023006704A (es) Composiciones dsg2 y metodos para el tratamiento de covid-19.
PH12021551975A1 (en) Use of vibegron to treat overactive bladder
MX2025006987A (es) Metodos para aumentar el bienestar mental y/o la felicidad
MX2023009620A (es) Metodos terapeuticos.
MX2025000682A (es) Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma
MX2023000151A (es) Terapia de combinacion de verapamilo y mometasona para el tratamiento de rinosinusitis cronica.
MX2023002947A (es) Composiciones y métodos para el tratamiento de distrofias musculares.
EP4467131A3 (en) Microbiota restoration therapy (mrt) compositions and methods of manufacture
MX2023008876A (es) Tratamiento de la apnea del sueño con cannabidiol (cbd).
CR20230190A (es) Compuesto degradante en un medicamento
MX2023008796A (es) Métodos para el tratamiento del trastorno del habla en niños.
ZA202202673B (en) Methods and compositions for treating endometriosis